Showing results (251-260 of 351) with videos related to
Sort By:
Pageof 36
Internal Medicine (Tokyo, Japan)|November 5, 2008
Natural human interferon beta plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus and a high viral loadYoshio Katamura, Fumitaka Suzuki, Norio Akuta, et al.Journal of Medical Virology|March 26, 2004
Severe acute exacerbation of liver disease may reduce or delay emergence of YMDD motif mutants in long-term lamivudine therapy for hepatitis B e antigen-positive chronic hepatitis BAkihito Tsubota, Yasuji Arase, Fumitaka Suzuki, et al.Journal of Gastroenterology|August 5, 2004
Peripheral CD8+/CD25+ lymphocytes may be implicated in hepatocellular injuries in patients with acute-onset autoimmune hepatitisYoshiyuki Suzuki, Mariko Kobayashi, Tetsuya Hosaka, et al.Drug Design, Development and Therapy|July 26, 2014
Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavirFumitaka Suzuki, Hitomi Sezaki, Norio Akuta, et al.Journal of Hepatology|June 5, 2012
Long-term continuous entecavir therapy in nucleos(t)ide-naïve chronic hepatitis B patientsAtsushi Ono, Fumitaka Suzuki, Yusuke Kawamura, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 19, 2021
Virologic analysis of tenofovir resistance in a patient with chronic hepatitis B experiencing viral breakthrough during combination treatment with tenofovir disoproxil fumarate and entecavirFumitaka Suzuki, Hitomi Sezaki, Tetsuya Hosaka, et al.Journal of Gastroenterology|October 5, 2016
Efficacy of long-term tenofovir-based rescue therapy in patients with chronic hepatitis B refractory to nucleoside/nucleotide analogsFumitaka Suzuki, Yoshiyuki Suzuki, Tetsuya Hosaka, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 11, 2012
Efficacy of reduction therapy of natural human β-interferon and ribavirin in elderly patients with chronic hepatitis C, genotype 2 and high virus loadYasuji Arase, Yoshiyuki Suzuki, Fumitaka Suzuki, et al.Anticancer Research|March 4, 2025
Efficacy of Lenvatinib and Atezolizumab Bevacizumab Combination Therapy in Patients With Combined Hepatocellular-cholangiocarcinomaNorikazu Tanabe, Issei Saeki, Kenji Yamaoka, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 23, 2012
Efficacy of reduction therapy of natural human β-interferon and ribavirin in elderly patients with chronic hepatitis C, genotype 1b and high viral loadYasuji Arase, Yusuke Kawamura, Yoshiyuki Suzuki, et al.Pageof 36